Tumor infiltrating lymphocytes to predict DFS from intense dose-dense (idd) EPC regimen: Results from the German Adjuvant Intergroup Node-positive study (GAIN-1).

Authors

null

Aurelia Noske

Institut für Pathologie, Technische Universität München, München, Germany

Aurelia Noske , Karsten Weber , Volker Moebus , Sabine Schmatloch , Wilko Weichert , Claus-Henning Kohne , Christine Solbach , Barbara Ingold Heppner , Katja Steiger , Volkmar Mueller , Peter A. Fasching , Thomas Karn , Marion van Mackelenbergh , Frederik Marme , Wolfgang D Schmitt , Christian Schem , Elmar Stickeler , Carsten Denkert , Sibylle Loibl

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Citation

J Clin Oncol 36, 2018 (suppl; abstr 527)

DOI

10.1200/JCO.2018.36.15_suppl.527

Abstract #

527

Poster Bd #

19

Abstract Disclosures

Similar Posters

First Author: Xue Wang

Poster

2018 Gastrointestinal Cancers Symposium

Association of COX-2 expression with lymphocyte infiltration in colorectal cancer.

Association of COX-2 expression with lymphocyte infiltration in colorectal cancer.

First Author: Zehua Wu

First Author: Benjamin Garrett Vincent